Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Three Drug Combinations for Intermittent Treatment of Malaria in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Age between 1 to 5 years at enrolment.~2. Informed consent obtained from parents or legal guardians.~3. No current participation in another malaria intervention trial.~4. Free of obvious health problems as established by medical history and clinical examination before entering into the study.~5. Available for the duration of the study.~Exclusion Criteria:~1. Known allergy to any of the antimalarial drugs used in the trial and if this is unknown, then a history of allergic reaction to any drug.~2. Acute or chronic, clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality, as determined by physical examination or laboratory tests.

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 5 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): SP+AQ
- 2 (Type: EXPERIMENTAL): Piperaquine plus SP arm
- 3 (Type: EXPERIMENTAL): Du-Cotecxin

Based on this trial design, predict the completion outcome and termination type (if applicable).